LINEAGE CELL THERAPEUTICS
Live / Applied — Second extension granted (statement of use) (as of 02 Jan 2026)
What this means for you
Not registered yet, but its 14 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97794652
- Mark type
- Design + words
- Filed
- 14 Feb 2023
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Harold Milstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and compositions for therapeutic use and treatment in the areas of ophthalmology, neurological conditions, oncology, neurotology; pharmaceutical preparations and compositions for cell therapy treatment and transplant medicine
Owner
- Lineage Cell Therapeutics, Inc., Carlsbad, CA, US
- Lineage Cell Therapeutics, Inc., Carlsbad, CA, US
Prosecution history
- 03 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jan 2026 — SOU EXTENSION 2 GRANTED
- 02 Jan 2026 — SOU EXTENSION 2 FILED
- 02 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jul 2025 — SOU EXTENSION 1 GRANTED
- 03 Jul 2025 — SOU EXTENSION 1 FILED
- 03 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION
- 20 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 May 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 23 May 2024 — LETTER OF SUSPENSION E-MAILED